Insider Shareholders with Direct Ownership of Protalix Bio Therapeutics, Inc. (PLX)
This section provides a comprehensive overview of the insiders with direct ownership of Protalix Bio Therapeutics, Inc. (PLX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Protalix BioTherapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Dexcel Pharma Technologies Ltd.
> 10% Shareholder |
0 | 918,717 | 3,637,314 $7.71 Million | 2 |
Jun 03, 2021
Reduced 19.08%
|
| 110,000 | 0 | 174,000 $368,880 | 1 |
Jan 03, 2023
Added 38.73%
|
|
|
Dror Bashan
PRESIDENT AND CEO |
132,516 | 0 | 132,516 $280,933 | 2 |
Oct 19, 2023
Added 10.85%
|